Medicare Enrolled
Dr. Rohit Amin, MD
Cardiovascular Disease · Pensacola, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amin? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amin
Dr. Rohit Amin is a cardiovascular disease in Pensacola, FL, with 18 years in practice. Based on federal Medicare data, Dr. Amin performed 3,821 Medicare services across 3,412 unique beneficiaries.
Between the years covered by Open Payments, Dr. Amin received a total of $626,443 from 57 pharmaceutical and/or device companies across 1455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 31% volume in FL$ $626,443 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,821
Medicare services
Top 31% in FL for cardiovascular disease
3,412
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~212 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 683 | $70 | $115 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 254 | $10 | $32 |
| Initial hospital admission, moderate complexity | 217 | $103 | $351 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 204 | $26 | $160 |
| EKG interpretation and report | 183 | $6 | $9 |
| New patient office visit (45-59 min) | 140 | $97 | $165 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 119 | $16 | $59 |
| Anticoagulant management of patient taking warfarin | 115 | $9 | $13 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 115 | $16 | $95 |
| Hospital follow-up visit, moderate complexity | 113 | $61 | $182 |
| Ultrasonic guidance for blood vessel access | 110 | $12 | $39 |
| Cardiac catheterization | 107 | $189 | $855 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 103 | $11 | $65 |
| Test for exercise-induced lung stress | 103 | $17 | $37 |
| Ultrasound of heart, follow-up | 92 | $20 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 83 | $60 | $356 |
| Ultrasound of leg arteries or artery grafts | 75 | $29 | $219 |
| Initial hospital admission, high complexity | 74 | $137 | $516 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 71 | $2 | $165 |
| Ultrasound of both sides of head and neck blood flow | 70 | $30 | $220 |
| Coronary stent placement | 65 | $425 | $1,637 |
| Heart muscle strain imaging | 56 | $9 | $22 |
| Ultrasound of heart with probe in esophagus, with report | 52 | $83 | $292 |
| Ultrasound of heart blood flow, valves and chambers | 51 | $14 | $47 |
| Hospital follow-up visit, high complexity | 45 | $92 | $262 |
| Hospital discharge management, 30+ min | 43 | $88 | $270 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 41 | $277 | $1,180 |
| Office visit, established patient, complex (40-54 min) | 34 | $113 | $162 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 30 | $149 | $320 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 27 | $78 | $229 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 24 | $74 | $250 |
| Critical care, first 30-74 min | 24 | $162 | $570 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 23 | $6 | $19 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 21 | $62 | $185 |
| Echocardiogram, transthoracic | 21 | $82 | $1,034 |
| Review by radiologist of major lower body vein image | 20 | $38 | $143 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 18 | $59 | $201 |
| Drug infusion during cardiac catheterization | 17 | $79 | $285 |
| Insertion of tube into vena cava | 16 | $46 | $329 |
| Review by radiologist of both arms or legs arteries image | 16 | $75 | $165 |
| Removal and dissolving of blood clot from vein using fluoroscopic guidance, initial treatment | 15 | $300 | $1,307 |
| Review by radiologist of abdominal aorta image | 15 | $56 | $144 |
| New patient office visit, complex (60-74 min) | 15 | $137 | $241 |
| External shock to heart to regulate heart beat | 14 | $81 | $823 |
| Ultrasound of one leg arteries or artery grafts | 14 | $17 | $96 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $187 | $1,010 |
| Emergency department visit, moderate complexity | 13 | $92 | $302 |
| Repair of mitral valve through the skin, initial prosthesis | 12 | $1,481 | $4,894 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 12 | $264 | $1,135 |
| Insertion of tube in right heart chambers for measurement | 12 | $85 | $397 |
| Balloon dilation of single coronary artery or branch | 11 | $368 | $1,473 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.9% high complexity
28.9% medium
61.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$626,443
Total received (2018-2024)
Avg $89,492/year across 7 years
Top 0% in FL for cardiovascular disease
57
Companies
1,455
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$546,570 (87.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$40,197 (6.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$39,675 (6.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$33,503
2023$53,048
2022$94,802
2021$105,016
2020$81,244
2019$155,603
2018$103,227
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$279,822
AstraZeneca Pharmaceuticals LP
$180,460
Inari Medical, Inc.
$69,567
Abbott Laboratories
$22,171
ABIOMED
$15,958
Bayer HealthCare Pharmaceuticals Inc.
$13,582
Novartis Pharmaceuticals Corporation
$10,170
Penumbra, Inc.
$6,068
Actelion Pharmaceuticals US, Inc.
$5,986
Ancora Heart, Inc.
$4,719
ShockWave Medical, Inc
$3,192
Edwards Lifesciences Corporation
$1,633
Medtronic, Inc.
$1,307
Janssen Pharmaceuticals, Inc
$1,241
Boston Scientific Corporation
$959
United Therapeutics Corporation
$875
ENDOTRONIX, INC.
$760
Boehringer Ingelheim Pharmaceuticals, Inc.
$702
Recor Medical Inc
$620
PFIZER INC.
$484
Imperative Care, Inc
$473
E.R. Squibb & Sons, L.L.C.
$465
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$431
Opsens Inc.
$390
Medtronic Vascular, Inc.
$354
AngioDynamics, Inc.
$325
Janssen Scientific Affairs, LLC
$303
PROCYRION, INC.
$299
SANOFI-AVENTIS U.S. LLC
$241
Cook Medical LLC
$241
Philips North America LLC
$240
LivaNova USA, Inc.
$208
Terumo Medical Corporation
$188
Gilead Sciences, Inc.
$176
W. L. Gore & Associates, Inc.
$169
SCPHARMACEUTICALS INC.
$158
Cardiovascular Systems Inc.
$134
HeartFlow, Inc.
$117
Merck Sharp & Dohme LLC
$107
BOSTON SCIENTIFIC CORPORATION
$103
CVRx, Inc.
$98
Osprey Medical Inc
$96
Contego Medical, Inc
$95
Shockwave Medical, Inc
$93
Chiesi USA, Inc.
$85
Novo Nordisk Inc
$84
Bolton Medical Inc
$84
CARDIVA MEDICAL, INC.
$82
Sensible Medical Innovations Inc
$80
Becton, Dickinson and Company
$69
Cardiac Assist, Inc.
$59
GE HEALTHCARE
$39
Philips Electronics North America Corporation
$25
Daiichi Sankyo Inc.
$19
iRhythm Technologies, Inc.
$16
Amarin Pharma Inc.
$13
PORTOLA PHARMACEUTICALS, INC.
$12
Top 3 companies account for 84.6% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (BR5) Peripheral IVUS · (BZ1) Tack Endovascular Systems BTK · ABSOLUTE PRO · AMPLATZER TALISMAN · ANDEXXA · ANGIOVAC · AORTIX SYSTEM · AccuCinch · Adempas · Advisor Catheter · Allure Quadra RF CRT Pacemaker · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · COOK MEDICAL ZILVER PTX · CORDELLA PULOMONARY ARTERY PRESSURE SENSOR · COREVALVE EVOLUT R · COROFLOW · CRT-Ds · CT THROMBECTOMY SYSTEM KIT · CardioMEMS HF System · Cook Medical Zenith · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DyeVert · ELIQUIS · ELUVIA · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · FlowTriever · GENERAL VASCULAR INTERVENTION · GENERAL PAIN MANAGEMENT · GLIDEWIRE · GORE CARDIOFORM Septal Occluder · General - Atherectomy · General - Therapies · General - Vascular Access · Gore Septal Occluder · HeartWare HVAD · INJECTAFER · INNOVA · INVOKANA · Impella · Indigo · Indigo System · JARDIANCE · JETI · JETI ALL IN ONE NON-STERILE KIT · JETI PERIPHERAL CATHETER · KENGREAL · LEQVIO · LOKELMA · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MITRACLIP · MULTAQ · MetaCross · Mitra Clip system · MitraClip System · OPSUMIT · OPSUMIT MACITENTAN · OPTIS · ORENITRAM · OptoWire · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PERCLOSE PROSTYLE · PRADAXA · PRALUENT · PRESSUREWIRE · PRODIGY CATHETER · Penumbra System · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · REMODULIN · RESONATE · ReDS system · Relay Plus · Repatha · Resolute · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SUPERA · SYMPHONY CATHETER · SYMPLICITY G3 · Saxenda · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripher · Supera peripheral stent system · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TR Band · TYRX · TYVASO · TandemHeart · TandemLife · Trilogy 100 · UPTRAVI · VENASEAL · VIABAHN VBX Balloon Expandable Endoprosthesis · Vascepa · VenaSeal · Venclose Maven Catheter · Verquvo · WALLSTENT · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · XARELTO · XIENCE V · Xact carotid stent system · Xience Alpine cornary stent system · Xience cornary stent systems · ZILVER PTX · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for cardiovascular disease in FL.
Equivalent to $16,395 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
37
Per 100K population
11.4
County median income
$65,715
Nearest hospital
SACRED HEART HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Amin is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 0%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Amin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Amin performed 683 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amin receive payments from pharmaceutical companies?
Yes. Dr. Amin received a total of $626,443 from 57 companies across 1,455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amin's costs compare to other cardiovascular diseases in Pensacola?
Dr. Amin's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Pensacola
Browse cardiovascular diseases in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Inari Medical, Inc. Payments to Doctors
See all physicians who received payments from Inari Medical, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology